Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1034) 1034
Newspaper Article (534) 534
Magazine Article (49) 49
Book / eBook (44) 44
Book Chapter (28) 28
Book Review (19) 19
Publication (11) 11
Dissertation (10) 10
Conference Proceeding (5) 5
Web Resource (5) 5
Patent (3) 3
Reference (3) 3
Trade Publication Article (3) 3
Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (588) 588
life sciences & biomedicine (541) 541
humans (516) 516
female (398) 398
oncology (287) 287
biological and medical sciences (230) 230
medical sciences (204) 204
breast cancer (192) 192
breast neoplasms - drug therapy (169) 169
middle aged (164) 164
adult (162) 162
tumors (141) 141
aged (123) 123
breast neoplasms - pathology (120) 120
male (110) 110
animals (97) 97
breast neoplasms - genetics (97) 97
cancer (89) 89
gynecology. andrology. obstetrics (89) 89
mammary gland diseases (86) 86
risk factors (86) 86
research (85) 85
breast neoplasms - metabolism (83) 83
trump, donald j (81) 81
abridged index medicus (79) 79
analysis (68) 68
treatment outcome (68) 68
antineoplastic combined chemotherapy protocols - therapeutic use (66) 66
pharmacology. drug treatments (66) 66
chemotherapy, adjuvant (64) 64
care and treatment (63) 63
pelosi, nancy (63) 63
antineoplastic agents (59) 59
health aspects (57) 57
medicin och hälsovetenskap (52) 52
social sciences (51) 51
general & internal medicine (50) 50
chemotherapy (49) 49
gene expression (48) 48
prognosis (47) 47
mice (45) 45
united states (45) 45
coronaviruses (44) 44
disease-free survival (43) 43
medicine, general & internal (43) 43
time factors (41) 41
breast neoplasms - surgery (40) 40
mutation (40) 40
funding (39) 39
meetings (39) 39
studies (39) 39
cell line, tumor (38) 38
international finance (38) 38
international trade (38) 38
presidents (38) 38
aged, 80 and over (37) 37
biochemistry & molecular biology (37) 37
lagarde, christine (37) 37
tumor cells, cultured (37) 37
antineoplastic agents, hormonal - therapeutic use (36) 36
medicine & public health (36) 36
us exports (36) 36
women (36) 36
adolescent (35) 35
breast neoplasms - mortality (35) 35
federal employees (35) 35
proteins (35) 35
tamoxifen - therapeutic use (35) 35
fundamental and applied biological sciences. psychology (34) 34
risk assessment (34) 34
breast neoplasms - therapy (33) 33
clinical trials (33) 33
drug therapy (33) 33
emerging markets (33) 33
genetic aspects (33) 33
receptors, estrogen - metabolism (33) 33
multidisciplinary sciences (32) 32
science & technology - other topics (32) 32
usage (32) 32
general aspects (31) 31
patients (31) 31
cell biology (30) 30
combined modality therapy (30) 30
covid-19 (30) 30
cyclophosphamide - administration & dosage (30) 30
randomized controlled trials as topic (30) 30
skin and connective tissue diseases (30) 30
surgery (30) 30
apoptosis - drug effects (29) 29
psychology (29) 29
trastuzumab (29) 29
dose-response relationship, drug (28) 28
genetics & heredity (28) 28
medicine (28) 28
mnuchin, steven t (28) 28
neoplasm staging (28) 28
pandemics (28) 28
antineoplastic agents - therapeutic use (27) 27
doxorubicin - administration & dosage (27) 27
dna methylation (26) 26
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (22) 22
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
UofT at Mississauga - Stacks (6) 6
OISE - Stacks (5) 5
UofT at Scarborough - Stacks (5) 5
Online Resources - Online (4) 4
St. Michael's College (John M. Kelly) - 3rd Floor (3) 3
Gerstein Science - Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Art - Library use only (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mathematical Sciences - Stacks (1) 1
Media Commons - Microtexts (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Curriculum Resources (1) 1
OISE - Lost (1) 1
OISE - Theses (1) 1
Providence Healthcare - Stacks (1) 1
Regis College - Stacks (1) 1
Richard Charles Lee Canada-Hong Kong - Library use only (1) 1
Robarts - Reference (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1746) 1746
Portuguese (5) 5
Spanish (3) 3
Japanese (2) 2
French (1) 1
German (1) 1
Norwegian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. An indispensable liberty
: the fight for free speech in nineteenth-century America
by Cronin, Mary M. editor. (Mary Margaret)
2016, ISBN 9780809334728, xii, 295
LAW | Media Studies | 19th Century | United States | SOCIAL SCIENCE | Legal History | Essays | HISTORY | Freedom of speech
Book
Details down arrow
2. Full Text Concurrent Doxorubicin Plus Docetaxel Is Not More Effective Than Concurrent Doxorubicin Plus Cyclophosphamide in Operable Breast Cancer With 0 to 3 Positive Axillary Nodes: North American Breast Cancer Intergroup Trial E 2197
by Lori J. Goldstein and Anne O'Neill and Joseph A. Sparano and Edith A. Perez and Lawrence N. Shulman and Silvana Martino and Nancy E. Davidson
Journal of clinical oncology, ISSN 0732-183X, 09/2008, Volume 26, Issue 25, pp. 4092 - 4099
Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Docetaxel | Proportional Hazards Models | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Neoplasm Metastasis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Doxorubicin - administration & dosage | Index Medicus | Breast Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Estrogen Carcinogenesis in Breast Cancer
by Yager, James D and Davidson, Nancy E
The New England journal of medicine, ISSN 0028-4793, 01/2006, Volume 354, Issue 3, pp. 270 - 282
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | General aspects | Medical sciences | Tumors | Receptors, Estrogen - metabolism | Signal Transduction | Humans | Risk Factors | Female | DNA Damage | Breast Neoplasms - chemically induced | Carcinogens - metabolism | Estrogens - adverse effects | Estrogens - metabolism | Breast Neoplasms - drug therapy | Women | Breast cancer | Health aspects | Risk factors | Estrogen | Hormone replacement therapy | Menopause | Estrogens | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
by Francis, Prudence A and Pagani, Olivia and Fleming, Gini F and Walley, Barbara A and Colleoni, Marco and Láng, István and Gómez, Henry L and Tondini, Carlo and Ciruelos, Eva and Burstein, Harold J and Bonnefoi, Hervé R and Bellet, Meritxell and Martino, Silvana and Geyer, Charles E and Goetz, Matthew P and Stearns, Vered and Pinotti, Graziella and Puglisi, Fabio and Spazzapan, Simon and Climent, Miguel A and Pavesi, Lorenzo and Ruhstaller, Thomas and Davidson, Nancy E and Coleman, Robert and Debled, Marc and Buchholz, Stefan and Ingle, James N and Winer, Eric P and Maibach, Rudolf and Rabaglio-Poretti, Manuela and Ruepp, Barbara and Di Leo, Angelo and Coates, Alan S and Gelber, Richard D and Goldhirsch, Aron and Regan, Meredith M and Int Breast Canc Study Grp and SOFT TEXT Investigators Grp and SOFT and TEXT Investigators and the International Breast Cancer Study Group
The New England journal of medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 2, pp. 122 - 137
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Breast Neoplasms - surgery | Follow-Up Studies | Neoplasm Recurrence, Local - prevention & control | Premenopause | Humans | Middle Aged | Kaplan-Meier Estimate | Breast Neoplasms - drug therapy | Young Adult | Antineoplastic Agents, Hormonal - adverse effects | Disease-Free Survival | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Adult | Female | Androstadienes - therapeutic use | Receptor, ErbB-2 | Chemotherapy, Adjuvant | Tamoxifen - adverse effects | Androstadienes - adverse effects | Aromatase Inhibitors - therapeutic use | Women | Care and treatment | Usage | Hormone therapy | Analysis | Breast cancer | Health aspects | Medical research | Oncology | Tamoxifen | Cancer therapies | Survival | ErbB-2 protein | Studies | Design | Chemotherapy | Hospitals | Womens health | Aromatase | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
by Albain, Kathy S, Prof and Barlow, William E, Prof and Shak, Steven, MD and Hortobagyi, Gabriel N, Prof and Livingston, Robert B, Prof and Yeh, I-Tien, Prof and Ravdin, Peter, Prof and Bugarini, Roberto, DStat and Baehner, Frederick L, MD and Davidson, Nancy E, Prof and Sledge, George W, Prof and Winer, Eric P, Prof and Hudis, Clifford, Prof and Ingle, James N, Prof and Perez, Edith A, Prof and Pritchard, Kathleen I, Prof and Shepherd, Lois, Prof and Gralow, Julie R, Prof and Yoshizawa, Carl, PhD and Allred, D Craig, Prof and Osborne, C Kent, Prof and Hayes, Daniel F, Prof and for The Breast Cancer Intergroup of North America and Breast Canc Intergrp N Amer and Breast Cancer Intergroup of North America
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 55 - 65
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Predictive Value of Tests | Recurrence | United States - epidemiology | Breast Neoplasms - secondary | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Gene Expression Profiling | Receptors, Estrogen - analysis | Genetic Testing - methods | Cyclophosphamide - therapeutic use | Patient Selection | Fluorouracil - therapeutic use | Breast Neoplasms - chemistry | Clinical Trials, Phase III as Topic | Time Factors | Postmenopause | Adult | Female | Retrospective Studies | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Lymphatic Metastasis | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Disease-Free Survival | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tamoxifen - therapeutic use | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Chemotherapy | Cyclophosphamide | Clinical trials | genomics | Breast cancer | Tamoxifen | Doxorubicin | Survival | Nodes | Post-menopause | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The search for ESR1 mutations in breast cancer
by Oesterreich, Steffi and Davidson, Nancy E
Nature genetics, ISSN 1061-4036, 12/2013, Volume 45, Issue 12, pp. 1415 - 1416
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Drug Resistance, Neoplasm - genetics | Animals | Estrogen Receptor alpha - genetics | Breast Neoplasms - pathology | Protein Interaction Domains and Motifs - genetics | Antineoplastic Agents, Hormonal - therapeutic use | Humans | Female | Mutation, Missense | Breast Neoplasms - drug therapy | Receptors | Breast cancer | Genetic aspects | Gene mutations | Identification and classification | Estrogen | Proteins | Studies | Clinical trials | Endocrine therapy | Ligands | Mutation | Drug dosages | Cancer therapies | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Parasitic Diseases of Wild Birds
by Atkinson, Carter T and Thomas, Nancy J and Hunter, D. Bruce
2009, 1. Aufl., ISBN 0813820812, 609
Veterinary Medicine - Zoo & Wildlife | Birds | Parasites | Diseases
eBook
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
by Romond, Edward H and Perez, Edith A and Bryant, John and Suman, Vera J and Geyer, Charles E and Davidson, Nancy E and Tan-Chiu, Elizabeth and Martino, Silvana and Paik, Soonmyung and Kaufman, Peter A and Swain, Sandra M and Pisansky, Thomas M and Fehrenbacher, Louis and Kutteh, Leila A and Vogel, Victor G and Visscher, Daniel W and Yothers, Greg and Jenkins, Robert B and Brown, Ann M and Dakhil, Shaker R and Mamounas, Eleftherios P and Lingle, Wilma L and Klein, Pamela M and Ingle, James N and Wolmark, Norman
The New England journal of medicine, ISSN 0028-4793, 10/2005, Volume 353, Issue 16, pp. 1673 - 1684
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | General aspects | Medical sciences | Tumors | Breast Neoplasms - surgery | Recurrence | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Antibodies, Monoclonal, Humanized | Doxorubicin - analogs & derivatives | Mastectomy | Adult | Female | Chemotherapy, Adjuvant | Heart Diseases - chemically induced | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Proportional Hazards Models | Breast Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Breast Neoplasms - mortality | Receptor, ErbB-2 - analysis | Trastuzumab | Women | Breast cancer | Drug therapy | Health aspects | FDA approval | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
by Edith A. Perez and Edward H. Romond and Vera J. Suman and Jong-Hyeon Jeong and Nancy E. Davidson and Charles E. Geyer Jr and Silvana Martino and Eleftherios P. Mamounas and Peter A. Kaufman and Norman Wolmark
Journal of clinical oncology, ISSN 0732-183X, 09/2011, Volume 29, Issue 25, pp. 3366 - 3373
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Combined treatments (chemotherapy of immunotherapy associated with an other treatment) | Pharmacology. Drug treatments | Tumors | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Young Adult | Antibodies, Monoclonal, Humanized | Carcinoma, Ductal, Breast - drug therapy | Time Factors | Adult | Female | Chemotherapy, Adjuvant | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Carcinoma, Ductal, Breast - surgery | Carcinoma, Lobular - surgery | Neoplasm Invasiveness | Survival Rate | Treatment Outcome | Combined Modality Therapy | Breast Neoplasms - drug therapy | Remission Induction | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Breast Neoplasms - mortality | Carcinoma, Lobular - drug therapy | Trastuzumab | Index Medicus | Bc6 | Original Reports | Bc5
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
by Francis, Prudence A and Regan, Meredith M and Fleming, Gini F and Láng, István and Ciruelos, Eva and Bellet, Meritxell and Bonnefoi, Hervé R and Climent, Miguel A and Da Prada, Gian Antonio and Burstein, Harold J and Martino, Silvana and Davidson, Nancy E and Geyer, Charles E and Walley, Barbara A and Coleman, Robert and Kerbrat, Pierre and Buchholz, Stefan and Ingle, James N and Winer, Eric P and Rabaglio-Poretti, Manuela and Maibach, Rudolf and Ruepp, Barbara and Giobbie-Hurder, Anita and Price, Karen N and Colleoni, Marco and Viale, Giuseppe and Coates, Alan S and Goldhirsch, Aron and Gelber, Richard D and Int Breast Canc Study Grp and SOFT Investigators and